Schmitz et al. (2012)

Summary of novel genes

Entity	Tier 1 genes	Tier 2 genes	Tier 3 genes
BL	4	15	0

--- config: sankey: showValues: true linkColor: target width: 600 height: 300 nodeAlignment: right prefix: '(' suffix: ' genes)' --- sankey-beta This study, New Tier 1, 4 New Tier 1, BL Tier 1, 4 This study, New Tier 2, 15 New Tier 2, BL Tier 2, 15 This study, New Tier 3, 0 New Tier 3, BL Tier 3, 0 All other BL studies, BL Tier 1, 28 All other BL studies, BL Tier 2, 57 All other BL studies, BL Tier 3, 70

Novel genes reported in this study

Tier 1

New gene	BL tier
DDX3X	1
FOXO1	1
PCBP1	1
TCF3	1

Tier 2

New gene	BL tier
C16orf48	2
DHCR7	2
ELP2	2
EXOSC6	2
FLYWCH1	2
GTSE1	2
KANK2	2
MKI67	2
MYO18A	2
NCOR2	2
PDCD11	2
TOP2A	2
WDR90	2
WHAMM	2
YY1AP1	2

Details

Schmitz, Roland, Ryan M. Young, Michele Ceribelli, Sameer Jhavar, Wenming Xiao, Meili Zhang, George Wright, et al. 2012. “Burkitt Lymphoma Pathogenesis and Therapeutic Targets from Structural and Functional Genomics.” Nature 490 (7418): 116–20. https://doi.org/10.1038/nature11378.

Disclaimer

The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.

In particular, let us know if you feel that an important citation is missing or if a paper has been cited incorrectly.

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

Share — copy and redistribute the material in any medium or format for any purpose, even commercially.

Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.